Aaron Peng, Ph.D. - Publications

Affiliations: 
2011 Pharmaceutical Sciences State University of New York, Buffalo, Buffalo, NY, United States 
Area:
Pharmacy, Pharmacology

8 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2012 Peng A, Kosloski MP, Nakamura G, Ding H, Balu-Iyer SV. PEGylation of a factor VIII-phosphatidylinositol complex: pharmacokinetics and immunogenicity in hemophilia A mice. The Aaps Journal. 14: 35-42. PMID 22173945 DOI: 10.1208/S12248-011-9309-2  0.797
2012 Peng A, Pisal DS, Doty A, Balu-Iyer SV. Phosphatidylinositol induces fluid phase formation and packing defects in phosphatidylcholine model membranes. Chemistry and Physics of Lipids. 165: 15-22. PMID 22024173 DOI: 10.1016/J.Chemphyslip.2011.10.002  0.706
2012 Gaitonde P, Peng A, Straubinger RM, Bankert RB, Balu-Iyer SV. Downregulation of CD40 signal and induction of TGF-β by phosphatidylinositol mediates reduction in immunogenicity against recombinant human Factor VIII. Journal of Pharmaceutical Sciences. 101: 48-55. PMID 21953409 DOI: 10.1002/Jps.22746  0.748
2011 Kosloski MP, Peng A, Varma PR, Fathallah AM, Miclea RD, Mager DE, Balu-iyer SV. Immunogenicity and pharmacokinetic studies of recombinant factor VIII containing lipid cochleates. Drug Delivery. 18: 246-54. PMID 21114461 DOI: 10.3109/10717544.2010.536269  0.727
2011 Gaitonde P, Peng A, Straubinger RM, Bankert RB, Balu-Iyer SV. Phosphatidylserine reduces immune response against human recombinant Factor VIII in Hemophilia A mice by regulation of dendritic cell function. Clinical Immunology (Orlando, Fla.). 138: 135-45. PMID 21094627 DOI: 10.1016/J.Clim.2010.10.006  0.732
2010 Peng A, Straubinger RM, Balu-Iyer SV. Phosphatidylinositol containing lipidic particles reduces immunogenicity and catabolism of factor VIII in hemophilia a mice. The Aaps Journal. 12: 473-81. PMID 20517659 DOI: 10.1208/S12248-010-9207-Z  0.774
2009 Peng A, Gaitonde P, Kosloski MP, Miclea RD, Varma P, Balu-Iyer SV. Effect of route of administration of human recombinant factor VIII on its immunogenicity in Hemophilia A mice. Journal of Pharmaceutical Sciences. 98: 4480-4. PMID 19499565 DOI: 10.1002/Jps.21765  0.666
2007 Miclea RD, Varma PR, Peng A, Balu-Iyer SV. Development and characterization of lipidic cochleate containing recombinant factor VIII. Biochimica Et Biophysica Acta. 1768: 2890-8. PMID 17936245 DOI: 10.1016/J.Bbamem.2007.08.001  0.768
Show low-probability matches.